NO20082918L - Prolegemidler for ER-selektive stoffer, fremgangsmate for deres fremstilling og farmasoytiske preparater som inneholder disse forbindelsene - Google Patents
Prolegemidler for ER-selektive stoffer, fremgangsmate for deres fremstilling og farmasoytiske preparater som inneholder disse forbindelseneInfo
- Publication number
- NO20082918L NO20082918L NO20082918A NO20082918A NO20082918L NO 20082918 L NO20082918 L NO 20082918L NO 20082918 A NO20082918 A NO 20082918A NO 20082918 A NO20082918 A NO 20082918A NO 20082918 L NO20082918 L NO 20082918L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- preparation
- drugs
- methods
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005057225A DE102005057225A1 (de) | 2005-11-29 | 2005-11-29 | Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
PCT/EP2006/011728 WO2007062876A1 (de) | 2005-11-29 | 2006-11-27 | Prodrugs er-beta-selektiver substanzen, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20082918L true NO20082918L (no) | 2008-06-27 |
Family
ID=37909446
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20082918A NO20082918L (no) | 2005-11-29 | 2008-06-27 | Prolegemidler for ER-selektive stoffer, fremgangsmate for deres fremstilling og farmasoytiske preparater som inneholder disse forbindelsene |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1957514A1 (zh) |
JP (1) | JP2009517426A (zh) |
KR (1) | KR20080072087A (zh) |
CN (1) | CN101316856A (zh) |
AU (1) | AU2006319382A1 (zh) |
BR (1) | BRPI0619237A2 (zh) |
CA (1) | CA2630438A1 (zh) |
CR (1) | CR9997A (zh) |
DE (1) | DE102005057225A1 (zh) |
EA (1) | EA200801272A1 (zh) |
EC (1) | ECSP088482A (zh) |
NO (1) | NO20082918L (zh) |
WO (1) | WO2007062876A1 (zh) |
ZA (1) | ZA200805658B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2932224A1 (en) | 2013-12-05 | 2015-06-11 | Karo Pharma Ab | Estrogen receptor beta agonists for use in treating mesothelioma |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2245694T3 (es) * | 2000-04-12 | 2006-01-16 | Schering Aktiengesellschaft | Derivados de 11beta-pentil- y 11beta-hexil-estra-1,3,5(10)-trienos sustituidos en la posicion 8beta. |
DE10027887A1 (de) * | 2000-05-31 | 2001-12-13 | Jenapharm Gmbh | Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
US7534780B2 (en) * | 2004-05-21 | 2009-05-19 | Bayer Schering Pharma Aktiengesellschaft | Estradiol prodrugs |
DE102004025966A1 (de) * | 2004-05-21 | 2005-12-15 | Schering Ag | Estradiol-Prodrugs |
-
2005
- 2005-11-29 DE DE102005057225A patent/DE102005057225A1/de not_active Ceased
-
2006
- 2006-11-27 CN CNA2006800447926A patent/CN101316856A/zh active Pending
- 2006-11-27 CA CA002630438A patent/CA2630438A1/en not_active Abandoned
- 2006-11-27 KR KR1020087015777A patent/KR20080072087A/ko not_active Application Discontinuation
- 2006-11-27 EP EP06829356A patent/EP1957514A1/de not_active Withdrawn
- 2006-11-27 EA EA200801272A patent/EA200801272A1/xx unknown
- 2006-11-27 BR BRPI0619237-8A patent/BRPI0619237A2/pt not_active Application Discontinuation
- 2006-11-27 JP JP2008542680A patent/JP2009517426A/ja active Pending
- 2006-11-27 WO PCT/EP2006/011728 patent/WO2007062876A1/de active Application Filing
- 2006-11-27 AU AU2006319382A patent/AU2006319382A1/en not_active Abandoned
-
2008
- 2008-05-20 CR CR9997A patent/CR9997A/xx not_active Application Discontinuation
- 2008-05-29 EC EC2008008482A patent/ECSP088482A/es unknown
- 2008-06-27 ZA ZA200805658A patent/ZA200805658B/xx unknown
- 2008-06-27 NO NO20082918A patent/NO20082918L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2630438A1 (en) | 2007-06-07 |
DE102005057225A1 (de) | 2007-05-31 |
ECSP088482A (es) | 2008-06-30 |
KR20080072087A (ko) | 2008-08-05 |
CR9997A (zh) | 2008-09-22 |
AU2006319382A1 (en) | 2007-06-07 |
ZA200805658B (en) | 2010-01-27 |
CN101316856A (zh) | 2008-12-03 |
EP1957514A1 (de) | 2008-08-20 |
BRPI0619237A2 (pt) | 2011-09-20 |
JP2009517426A (ja) | 2009-04-30 |
EA200801272A1 (ru) | 2008-10-30 |
WO2007062876A1 (de) | 2007-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090628L (no) | Pyridizinon derivativater | |
EA201000436A1 (ru) | Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью | |
NO20092004L (no) | 2-[L-fenyl-5-hydroksy-4-alfa-metyl-heksahydrosyklopenta[f]indazol-5-yl]etylfenylderivater som glukokortikoidreseptorligandere | |
MX2009004746A (es) | Derivados de 1,2,4-triazol como inhibidores del receptor sigma. | |
NO20090295L (no) | Substituerte heteroarylderivater | |
CL2008001839A1 (es) | Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades. | |
SG163585A1 (en) | Melanocortin receptor ligands | |
MX2009002274A (es) | Compuestos de enlace fxr heterociclicos. | |
WO2008036168A3 (en) | New small molecule inhibitors of mdm2 and the uses thereof | |
NO20085176L (no) | Fenyl substituerte heteroaryl-derivater og andvendelse som anti-tumor agenter | |
MX2009005048A (es) | Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona. | |
BRPI0915084B8 (pt) | composto, e, composição farmacêutica | |
BRPI0712631B8 (pt) | compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações | |
NO20074002L (no) | Androgen reseptor-modulatorforbindelser og fremgangsmater | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO20082285L (no) | 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer | |
ATE485261T1 (de) | Salicylsäurederivate | |
WO2008156677A3 (en) | Cyclic peptide melanocortin receptor ligands | |
BRPI0806789B8 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
BRPI0512986A (pt) | novos derivados de hidantoìna | |
NO20065885L (no) | Steroide prolegemidler med androgen virkning | |
WO2009040314A3 (de) | Neue heteroarylsubstituierte acetonderivate, geeignet zur hemmung der phospholipase a2 | |
NO20014961L (no) | Integrin-reseptor-ligander | |
NO20082918L (no) | Prolegemidler for ER-selektive stoffer, fremgangsmate for deres fremstilling og farmasoytiske preparater som inneholder disse forbindelsene | |
NO20082913L (no) | Prolegemidler som er ERbeta-selektive substanser, fremgangsmater for deres fremstilling og farmasoytiske preparater inneholdende disse forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |